Bringing the fundamentals into focus…
Back to Abeona Therapeutics Inc.
How Abeona Therapeutics Inc. stacks up
ABEO · against 295 other Healthcare companies of similar size
Profitability
8/ 100
Near the bottom of its peers.
Ranked #259 of 296 · scores higher than 11% of peers
Bars: peers in each 10-point band of the profitability score43 peers with a profitability score of 0–9, including ABEO · Click a bar to see the companies
Why profitability scores 8?
Weighted metrics compared with all Healthcare companies.Mainly because of its return on assets, operating margin and return on invested capital, which are weaker than most Healthcare peers.
- a lower return on assets: weaker than 99% of peers. Return on assets: -114.3% vs peer median 1.7%
- a thinner operating margin: weaker than 91% of peers. Operating margin: -327.6% vs peer median 7.1%
- a lower return on invested capital: weaker than 91% of peers. Return on invested capital: -76.1% vs peer median 4.7%
Metric by metric
Position: dot = ABEO, ranked from the worst peer (left) to the best (right); tick = middle, shaded = middle half of peers.| Metric | ABEO | Peer median | Better than | Position among peers | Weight |
|---|---|---|---|---|---|
| Return on invested capitalHigher is better · 256 reported | -76.1% | -1.2% | 12% | 33% | |
| Operating marginHigher is better · 275 reported | -327.6% | 2.0% | 12% | 33% | |
| Return on assetsHigher is better · 298 reported | -114.3% | -0.8% | 2% | 33% | |
| Return on equityHigher is better · 278 reported | -43.1% | -1.6% | 22% | Context only | |
| Gross marginHigher is better · 312 reported | -39.9% | 37.6% | 5% | Context only |
Ranking by profitability score
Top 5 and the companies ranked around ABEO| Rank | Company | Market cap | Profitability | Overall |
|---|---|---|---|---|
| 1 | 433M USD | 99 | 81 | |
| 2 | 261M USD | 98 | 97 | |
| 3 | 1.4B HKD (≈$181M) | 97 | 61 | |
| 3 | 356M AUD (≈$235M) | 97 | 81 | |
| 5 | 592M ILS (≈$160M) | 96 | 84 | |
| 254 | 399M USD | 9 | 32 | |
| 254 | 455M USD | 9 | 36 | |
| 254 | 3.9B SEK (≈$385M) | 9 | 23 | |
| 254 | 468M USD | 9 | 40 | |
| 259 | 243M USD | 8 | 27 | |
| 259 | 357M USD | 8 | 32 | |
| 259 | 172M USD | 8 | 41 | |
| 259 | 264M USD | 8 | 30 | |
| 259 | 332M USD | 8 | 35 |
Scores are sector-relative percentiles from the latest snapshot, always calculated against the whole sector: narrowing the comparison group changes who you compare with, not the scores. Missing metrics are left out and the remaining weights rescaled. How we score